Kobe University

Central Japan Startup Ecosystem Holds Symposium on "Homeland of Mobility 5.0 - Leading Society to the Next Generation"

Retrieved on: 
星期五, 三月 1, 2024
Engineering, Toyota, Doctor of Philosophy, Culture, Future, Database, Perception, Harvard Business Review, University, History, Maglev, Local government, Car, Transport, Woman, Entrepreneurship, Sophia University, Automotive News, Ecosystem, Environment, Research, Female, Generator, Carbon, City, Collision course, News, Speech, Kobe University, Innovation, Economic development, Maas, Culture war, Risk, Nanzan University, Marubeni, Movement, Area studies, Mobility, Management

The symposium was a hybrid event focusing on Central Japan's commitment to being the "Homeland of Mobility 5.0 - Leading Society to the Next Generation."

Key Points: 
  • The symposium was a hybrid event focusing on Central Japan's commitment to being the "Homeland of Mobility 5.0 - Leading Society to the Next Generation."
  • The event effectively communicated the strength of the Central Japan Ecosystem to overseas media and successfully achieved coverage in key media.
  • Toshio Sumi (Director, Economic Affairs Bureau Startup Support Office, Innovation Department, Nagoya City Economic Affairs Bureau) provided an overview of Central Japan, its history of innovation and manufacturing, and initiatives from the Central Japan Startup Ecosystem.
  • Central Japan Startup Ecosystem provides everything a startup needs – from highly trained workers in many specialized fields to opportunities to conduct feasibility studies with leading companies in various industries including the mobility sector.

Central Japan Startup Ecosystem Holds Symposium on "Homeland of Mobility 5.0 - Leading Society to the Next Generation"

Retrieved on: 
星期五, 三月 1, 2024
Engineering, Toyota, Doctor of Philosophy, Culture, Future, Database, Perception, Harvard Business Review, University, History, Maglev, Local government, Car, Transport, Woman, Entrepreneurship, Sophia University, Automotive News, Ecosystem, Environment, Research, Female, Generator, Carbon, City, Collision course, News, Speech, Kobe University, Innovation, Economic development, Maas, Culture war, Risk, Nanzan University, Marubeni, Movement, Area studies, Mobility, Management

The symposium was a hybrid event focusing on Central Japan's commitment to being the "Homeland of Mobility 5.0 - Leading Society to the Next Generation."

Key Points: 
  • The symposium was a hybrid event focusing on Central Japan's commitment to being the "Homeland of Mobility 5.0 - Leading Society to the Next Generation."
  • The event effectively communicated the strength of the Central Japan Ecosystem to overseas media and successfully achieved coverage in key media.
  • Toshio Sumi (Director, Economic Affairs Bureau Startup Support Office, Innovation Department, Nagoya City Economic Affairs Bureau) provided an overview of Central Japan, its history of innovation and manufacturing, and initiatives from the Central Japan Startup Ecosystem.
  • Central Japan Startup Ecosystem provides everything a startup needs – from highly trained workers in many specialized fields to opportunities to conduct feasibility studies with leading companies in various industries including the mobility sector.

Insurance Solutions Provider Orion180 Names 4 to Leadership Team

Retrieved on: 
星期二, 十一月 14, 2023
Apps, Applications, Technology, Insurance, Finance, Fintech, Professional Services, Software, Data Analytics, Data Management, Kobe University, Associate, Record, ARM, Personal, LexisNexis Risk Solutions, Rhode Island College, WTW, ERM, University, Commercial, Risk, Equitable, Are, Florida Army National Guard, Utica National Museum, Crosier, University of Massachusetts Dartmouth, AIC, Doctor of Philosophy, Marketing, Liberty Mutual, AIG, Army, Chartered Property Casualty Underwriter, Citizens Insurance, Liability (financial accounting), SVP, Growth, AIDA, API, CPCU, University of Hartford, Risk management, Management

They expand our agility and technology-centric knowledge in key areas and complement our strong existing team at Orion180,” says Kenneth Gregg, CEO and founder of Orion180.

Key Points: 
  • They expand our agility and technology-centric knowledge in key areas and complement our strong existing team at Orion180,” says Kenneth Gregg, CEO and founder of Orion180.
  • “These appointments signal our preparedness to compete in multiple lines of personal and commercial insurance as we look to expand nationally.”
    Mohammad Javanbarg, SVP of specialty risk, joined Orion180 to customize and enhance Orion180's view of modeled and non-modeled catastrophe risks, and develop innovative specialty insurance solutions.
  • Malcolm Tsung, VP of product management, commercial lines, joined Orion180 to spearhead the development of Orion180’s commercial lines products.
  • Before joining Orion180, at LexisNexis Risk Solutions, he served as director, commercial insurance vertical.

Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan

Retrieved on: 
星期三, 十二月 6, 2023
Kobe University, NYSE, DNA, Gene, Marketing, Synthetic biology, Postgraduate education, AAV, MOU, Vaccine, Ginkgo

Together, Synplogen and Ginkgo intend to accelerate the global development of DNA manufacturing and gene therapy platform services in Japan.

Key Points: 
  • Together, Synplogen and Ginkgo intend to accelerate the global development of DNA manufacturing and gene therapy platform services in Japan.
  • Ginkgo and Synplogen will explore global business collaboration opportunities for DNA manufacturing.
  • Synplogen's OGAB™ DNA synthesis services have the ability to synthesize DNA of various lengths up to 100 kbp.
  • Furthermore, Ginkgo and Synplogen will work to extend the reach of Ginkgo's gene therapy services in Japan.

Morpho’s "SoftNeuro" Enables 19x Faster Inference of 3D Simulation on Fugaku

Retrieved on: 
星期三, 二月 8, 2023
Data Management, Satellite, Technology, Audio, Video, Software, Artificial Intelligence, Hardware, University, Deep learning, Kobe University, Fugaku, Tohoku University, Television

Morpho, Inc. (hereinafter, “Morpho”)(TOKYO: 3653), a global leader in image processing and imaging AI solutions, announced today that it has provided deep learning inference engine “SoftNeuro®” to a project promoted by the University of Tokyo, Tohoku University, and Kobe University to accelerate high-resolution galaxy formation simulations using deep learning on the supercomputer Fugaku.

Key Points: 
  • Morpho, Inc. (hereinafter, “Morpho”)(TOKYO: 3653), a global leader in image processing and imaging AI solutions, announced today that it has provided deep learning inference engine “SoftNeuro®” to a project promoted by the University of Tokyo, Tohoku University, and Kobe University to accelerate high-resolution galaxy formation simulations using deep learning on the supercomputer Fugaku.
  • The result is approx.
  • 19.2 times faster inference time(*1) and approx.
  • 93% reduction(*2) in power consumption.

Kobe University research: Healthy gut, healthy heart: Gut bacteria and heart disease

Retrieved on: 
星期五, 十二月 9, 2022
Water, Degenerative disease, AAA, Aorta, Ligand, Heart, Spleen, Immune system, Angiotensin, Development, Monocyte, Aortic rupture, Hypertension, Cardiac arrest, Bacteria, NOD1, Patient, Abdominal aortic aneurysm, Internal bleeding, Research, Injection, Cardiovascular disease, Incidence, Kobe University, Death, Bone marrow, AAAS, Tissue, Inflammation, Rupture, Stroke, Swelling, Risk, Pharmaceutical industry, Restaurant, Vaccine, Dietary supplement, Mouse

In a recent collaboration between Kobe University and the gut bacteriafocused company Noster Inc., a team led by Tomoya Yamashita has revealed the importance of gut bacteria in the development of AAA.

Key Points: 
  • In a recent collaboration between Kobe University and the gut bacteriafocused company Noster Inc., a team led by Tomoya Yamashita has revealed the importance of gut bacteria in the development of AAA.
  • The composition of bacteria normally residing in the gut is known to play a role in other cardiovascular diseases.
  • The suppression of gut bacteria was, thus, somehow leading to a reduced risk of AAA.
  • This study revealed the link between gut bacteria and the onset of AAA.

Kobe University research: Healthy gut, healthy heart: Gut bacteria and heart disease

Retrieved on: 
星期五, 十二月 9, 2022
Water, Degenerative disease, AAA, Aorta, Ligand, Heart, Spleen, Immune system, Angiotensin, Development, Monocyte, Aortic rupture, Hypertension, Cardiac arrest, Bacteria, NOD1, Patient, Abdominal aortic aneurysm, Internal bleeding, Research, Injection, Cardiovascular disease, Incidence, Kobe University, Death, Bone marrow, AAAS, Tissue, Inflammation, Rupture, Stroke, Swelling, Risk, Pharmaceutical industry, Restaurant, Vaccine, Dietary supplement, Mouse

In a recent collaboration between Kobe University and the gut bacteriafocused company Noster Inc., a team led by Tomoya Yamashita has revealed the importance of gut bacteria in the development of AAA.

Key Points: 
  • In a recent collaboration between Kobe University and the gut bacteriafocused company Noster Inc., a team led by Tomoya Yamashita has revealed the importance of gut bacteria in the development of AAA.
  • The composition of bacteria normally residing in the gut is known to play a role in other cardiovascular diseases.
  • The suppression of gut bacteria was, thus, somehow leading to a reduced risk of AAA.
  • This study revealed the link between gut bacteria and the onset of AAA.

Morpho Provides “SoftNeuro” to Highly Resolved Galaxy Simulations Project for Universities: Supporting 3D Simulation with Supercomputer Fugaku

Retrieved on: 
星期一, 十二月 5, 2022
University, Data Management, Education, Technology, Research, Photography, Software, Artificial Intelligence, Networks, Audio, Video, Science, University, Culture, SN, Explosion, Acceleration, CNN, Communication, Morpho, Tohoku University, SVE, Inc., 3D, Deep learning, Kobe University, Forecasting, Socs, 3D printing, Fugaku

"SoftNeuro" will accelerate the inference of 3D simulations (galaxy formation simulations) using deep learning on the supercomputer Fugaku.

Key Points: 
  • "SoftNeuro" will accelerate the inference of 3D simulations (galaxy formation simulations) using deep learning on the supercomputer Fugaku.
  • For this project, Morpho has realized 3D CNN inference acceleration on Fugaku (SVE optimization of Conv3D and application of 3D Winograd) through the original development of "SoftNeuro" for use in 3D simulations.
  • Through the project and collaboration, Morpho will support further acceleration of 3D simulations (galaxy formation simulations) using deep learning on supercomputer Fugaku.
  • The project is to accelerate highly resolved galaxy formation simulations.

Diagnostic Imaging against Storage Battery Explosion: Toward the Dissemination of Next-Generation Storage Batteries

Retrieved on: 
星期三, 九月 14, 2022
Exhibition, Safety, Ageing, Accident, THE, KOBE, Japanese Journal of Applied Physics, Technology, MI, Physics, Kobe University, Multimedia, Electrical resistivity and conductivity, Suburban Collection Showplace, Electric battery, Electrochemistry

KOBE, Japan, Sept. 14, 2022 /PRNewswire/ -- Integral Geometry Science Inc. (https://www.ig-instrum.co.jp/), a Japanese deep tech imaging startup, releases an innovative inspection system, which will enable battery manufacturers to detect products having ignition risks with higher-precision. The system is applied with a theory of inverse problem, developed by Professor Kenjiro Kimura of Kobe University Japan, for the first time in applied mathematics history.

Key Points: 
  • Storage batteries are used in many fields for the purpose of storing energy generated.
  • Storage batteries are applied to aging tests before shipment, and only good batteries are distributed in the market.
  • However, accidents such as ignition have occurred though batteries pass these safety tests.
  • A sophisticated good/failure discrimination system is essentially required to eliminate theses batteries with non-uniform electric current density distribution.

MIMEDX EPIFIX® Receives Reimbursement Approval in Japan

Retrieved on: 
星期一, 九月 12, 2022
Diabetes, Sterilization, Engineering, Department, VLU, Ulcer, Podiatry, Society, Company, Mouth ulcer, Infection, Amputation, Patient, Physician, Plastic, Allotransplantation, DFU, General manager, Tissue, Kobe University, GLOBE, Awareness, Biology, Good tissue practice, Education, Pharmaceutical industry, Health

MARIETTA, Ga., Sept. 12, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that the Japanese Ministry of Health, Labour and Welfare (JMHLW) approved reimbursement of EPIFIX® to treat refractory or hard-to-heal lower extremity diabetic and venous ulcers. The Company is in the last stages of preparing for full product launch, anticipated in the fourth quarter. The Company estimates the Japanese total addressable market associated with the scope of the JMHLW reimbursement decision to be approximately $500 million based on a recently completed third party market study. The study estimated that there are more than 400,000 hard-to-heal wounds that present each year in Japan that can be treated by EPIFIX and which qualify for reimbursement under the JMHLW’s decision.

Key Points: 
  • The study estimated that there are more than 400,000 hard-to-heal wounds that present each year in Japan that can be treated by EPIFIX and which qualify for reimbursement under the JMHLWs decision.
  • Achieving reimbursement was a key pre-requisite to launch EPIFIX in Japan, and we think the awarded rate of 35,100 Yen/cm2 will be very favorable in supporting market adoption, said Rohit Kashyap, Ph.D., MIMEDX President, Wound Care & Surgical.
  • I am very excited to have reimbursement acceptance for EPIFIX in Japan, and I believe many patients and physicians will benefit from having a new treatment option for chronic wounds caused by lower extremity diabetic and venous ulcers.
  • EPIFIX is a PURION processed placental tissue allograft that supports the healing cascade by providing a protective barrier over wounds.